An Ovine Model of Toxic, Nonischemic Cardiomyopathy-Assessment by Cardiac Magnetic Resonance Imaging

Journal of Cardiac Failure

Volumn 14, Issue 9, 2008, Pages 785-795

  Psaltis, Peter J ^a,b   Carbone, Angelo ^a   Nelson, Adam ^a   Lau, Dennis H ^a,b   Manavis, Jim ^c   Finnie, John ^c   Teo, Karen S ^a   Mackenzie, Lorraine ^a,b   Sanders, Prashanthan ^a,b   Gronthos, Stan ^d   Zannettino, Andrew C W ^b,d   Worthley, Stephen G ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c HANSON INSTITUTE   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

animal model; Cardiomyopathy; magnetic resonance imaging; nonischemic

Indexed keywords

DOXORUBICIN; GADOLINIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOMYOPATHY; CELL DEGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UPTAKE; ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART RATE; HEART VENTRICLE PRESSURE; MORTALITY; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHEEP; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR DISEASE;

ANIMALS; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; MAGNETIC RESONANCE IMAGING; SHEEP, DOMESTIC;

EID: 55149111422     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.06.449     Document Type: Article

References (37)

1. Fonarow G.C. Heart failure: recent advances in prevention and treatment. Rev Cardiovasc Med 1 (2000) 25-33 54
2. Jessup M., Brozena S. Heart failure. N Engl J.M. 2003;348:2007-2018.
3. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat Biotechnol 23 (2005) 845-856
4. Follath F. Ischemic versus non-ischemic heart failure: should the etiology be determined?. Heart Fail Mon 1 (2001) 122-125
5. Agbulut O., Menot M.L., Li Z., Marotte F., Paulin D., Hagege A.A., et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 58 (2003) 451-459
6. Borenstein N., Chetboul V., Bruneval P., Hekmati M., Tissier R., Behr L., et al. Non-cultured cell transplantation in an ovine model of non-ischemic heart failure. Eur J Cardiothorac Surg 31 (2007) 444-451
7. Aupperle H., Garbade J., Schubert A., Barten M., Dhein S., Schoon H.A., et al. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model. Vet Pathol 44 (2007) 494-503
8. Yarbrough W.M., and Spinale F.G. Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications. J Nucl Cardiol 10 (2003) 77-86
9. Takemura G., and Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Progress Cardiovasc Dis 49 (2007) 330-352
10. Swain S.M., Whaley F.S., and Ewer M.S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97 (2003) 2869-2879
11. Borenstein N., Bruneval P., Behr L., Laborde F., Montarras D., Daures J.P., et al. An ovine model of chronic heart failure: echocardiographic and tissue Doppler imaging characterization. J Cardiac Surg 21 (2006) 50-56
12. Teo K.S., Carbone A., Piantadosi C., Chew D.P., Hammett C.J., Brown M.A., et al. Cardiac MRI assessment of left and right ventricular parameters in healthy Australian normal volunteers. Heart Lung Circ 17 (2008) 313-317
13. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
14. McCrohon J.A., Moon J.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
15. Jerosch-Herold M., Seethamraju R.T., Swingen C.M., Wilke N.M., and Stillman A.E. Analysis of myocardial perfusion MRI. J Magn Reson Imaging 19 (2004) 758-770
16. Eriksson H. Heart failure: a growing public health problem. J Intern Med 237 (1995) 135-141
17. Gertz E.W., Stam Jr. A.C., and Sonnenblick E.H. A quantitative and qualitative defect in the sarcoplasmic reticulum in the hereditary cardiomyopathy of the Syrian hamster. Biochem Biophys Res Communi 40 (1970) 746-753
18. Tidholm A., Svensson H., and Sylven C. Survival and prognostic factors in 189 dogs with dilated cardiomyopathy. J Am Animal Hosp Assoc 33 (1997) 364-368
19. Yamamoto K., Burnett Jr. J.C., Meyer L.M., Sinclair L., Stevens T.L., and Redfield M.M. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol 271 (1996) R1529-R1534
20. Recchia F.A., and Lionetti V. Animal models of dilated cardiomyopathy for translational research. Vet Res Commun 31 Suppl 1 (2007) 35-41
21. Aoyagi T., Mirsky I., Flanagan M.F., Currier J.J., Colan S.D., and Fujii A.M. Myocardial function in immature and mature sheep with pressure-overload hypertrophy. Am J Physiol 262 (1992) H1036-H1048
22. Nakano K., Swindle M.M., Spinale F., Ishihara K., Kanazawa S., Smith A., et al. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J Clin Invest 87 (1991) 2077-2086
23. Tanaka R., Spinale F.G., Crawford F.A., and Zile M.R. Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs. J Am Coll Cardiol 20 (1992) 1650-1660
24. Spinale F.G., Holzgrefe H.H., Mukherjee R., Arthur S.R., Child M.J., Powell J.R., et al. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol 268 (1995) H836-H847
25. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 339 (1998) 900-905
26. Kalyanaraman B., Joseph J., Kalivendi S., Wang S., Konorev E., and Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234-235 (2002) 119-124
27. Schwarz E.R., Pollick C., Dow J., Patterson M., Birnbaum Y., and Kloner R.A. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovasc Res 39 (1998) 216-223
28. Ditchey R.V., LeWinter M.M., and Higgins C.B. Acute effects of doxorubicin (Adriamycin) on left ventricular function in dogs. Int J Cardiol 6 (1984) 341-353
29. Tessier D., Lajos P., Braunberger E., Pouchelon J.L., Carpentier A., Chachques J.C., et al. Induction of chronic cardiac insufficiency by arteriovenous fistula and doxorubicin administration. J Cardiac Surg 18 (2003) 307-311
30. Chekanov V.S. A stable model of chronic bilateral ventricular insufficiency (dilated cardiomyopathy) induced by arteriovenous anastomosis and doxorubicin administration in sheep. J Thorac Cardiovasc Surg 117 (1999) 198-199
31. Toyoda Y., Okada M., and Kashem M.A. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. J Thorac Cardiovasc Surg 115 (1998) 1367-1373
32. Monnet E., and Orton E.C. A canine model of heart failure by intracoronary Adriamycin injection: hemodynamic and energetic results. J Cardiac Fail 5 (1999) 255-264
33. Magovern J.A., Christlieb I.Y., Badylak S.F., Lantz G.C., and Kao R.L. A model of left ventricular dysfunction caused by intracoronary Adriamycin. Ann Thorac Surg 53 (1992) 861-863
34. Bright J.M., and Buss D.D. Effects of verapamil on chronic doxorubicin-induced cardiotoxicity in dogs. J Natl Cancer Inst 82 (1990) 963-964
35. Stork A., Mullerleile K., Bansmann P.M., Koops A., Meinertz T., Adam G., et al. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies]. Rofo 179 (2007) 21-30
36. Gottlieb I., Macedo R., Bluemke D.A., and Lima J.A. Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev 11 (2006) 313-323
37. Rabkin S.W., and Bose D. Adriamycin induced alterations in canine Purkinje fiber action potential. Res Commun Chem Pathol Pharmacol 34 (1981) 55-67